Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Step-up and step-down treatment approaches for COPD | COPD
2 Leukocyte Function in COPD: Clinical Relevance | COPD
3 Impact of Covid-19 on patients with COPD | COPD
4 Corticosteroid therapy in bronchiectasis and all-cause morta | COPD
5 Sputum protein biomarkers in airway diseases: A pilot study. | COPD
6 Quality of life by asthma severity | JAA
7 Perplexing mortality data from triple therapy trials in COPD
8 Mast cell and basophil dysregulation in eosinophilic COPD | COPD
9 Burden of disease among exacerbating patients with COPD | COPD
10 Clinical evolution of COPD | COPD
11 Variability of COPD Inhaler Coverage in Medicare Part D
12 Bronchial diseases are insufficiently defined with COPD | COPD
13 Chiesi Group receives European Marketing Authorization for
14 Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
15 A Prospective Cohort Study to Assess Obstructive Respiratory Disease P | COPD
16 What is the impact of GOLD 2017 recommendations in primary care? &ndas | COPD
17 Factors Associated with Chronic Obstructive Pulmonary Diseases in Nepa | COPD
18 Automated oxygen control with O2matic® during admission with exace | COPD
19 Factors influencing length of hospital stay in COPD | COPD
20 Factors for COPD re-admissions among older adults | COPD
21 Clinical Control Criteria to Determine Disease Control in Patients wit | COPD
22 The Manchester Respiratory-related Sleep Symptoms scale for patients w | COPD
23 FEV1:FVC ratio diagnostic threshold optimal for predicting COPD prognosis
24 GOLD and COPD: Definition, stages, and more
25 Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moder | COPD
26 Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT
27 The dose of inhaled corticosteroids in patients with COPD: when less i | COPD
28 Predicting Hospitalization Due to COPD Exacerbations in Swedish Primar | COPD
29 Risk factors for respiratory hospitalizations in a population of patie | COPD
30 Diagnosis, assessment, and phenotyping of COPD: beyond FEV1 | COPD
31 Comparison of the clinical characteristics and comprehensive assessmen | COPD
32 Changes in definition lead to changes in the clinical characteristics | COPD
33 [Full text] Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD | COPD
34 Prediction models for exacerbations in different COPD patient populati | COPD
35 Risk of Congestive Heart Failure Associated with Aclidinium | COPD
36 Chronic obstructive pulmonary disease: diagnosis and management
37 Economic Burden of COPD by Disease Severity – A Nationwide Cohor | COPD
38 Exploring PI3Kδ molecular pathways in stable COPD | COPD
39 Association of socioeconomic deprivation with asthma care, outcomes, and deaths in Wales: A 5-year national linked primary and secondary care cohort study
40 2017 Global Initiative for Chronic Obstructive Lung Disease reclassif | COPD
41 Can we predict the prognosis of COPD with a routine blood test? | COPD
42 Clinical characteristics and related risk factors of depression in pat | COPD
43 Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis
44 Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients | COPD
45 Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Imp | COPD
46 Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary disease
47 Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan
48 Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis
49 Small Airways Disease, Biomarkers and COPD: Where are We? | COPD
50 When is dual bronchodilation indicated in COPD? | COPD
51 Treatment of COPD groups GOLD A and B | COPD
52 The Perception of Physicians on Gender-Specific Differences in the Dia | COPD
53 Patterns of Long-Acting Bronchodilator Use in COPD Patients | COPD
54 Information Needs in COPD After an Educational Programme: Influence in | COPD
55 Inhaled therapies in patients with moderate COPD in clinical practice: | COPD
56 Influence of statins on the exacerbation rate in COPD | IJGM
57 Determinants of incident asthma–COPD overlap: a prospective stud | CLEP
58 COPD: Delving Into Inhaler Adherence
59 CHARACTERISTICS OF COPD PHENOTYPES IN SERBIA | COPD
60 Processed Meat Intake and Risk of Chronic Obstructive Pulmonary Disease among Middle-aged Women
61 Longitudinal changes in lung hyperinflation in COPD | COPD
62 American Journal of Respiratory and Critical Care Medicine | Articles in Press
63 COPD Management in Community Pharmacy Results in Improved Inhaler Use, | COPD
64 Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy | COPD
65 Catching 'early' COPD – the diagnostic conundrum | COPD Early disease in COPD is difficult to
66 Neurological and Psychiatric Comorbidities in Chronic Obstructive Pulm | COPD
67 Different impacts of respiratory symptoms and comorbidities on COPD-sp | COPD
68 PARC/CCL18 in Chronic Obstructive Pulmonary Disease | COPD
69 Applying the wisdom of stepping down inhaled corticosteroids in patien | COPD
70 Day-to-Day Variability of Parameters Recorded by Home Noninvasive Posi | COPD
71 Epithelial cell–specific loss of function of Miz1 causes a spontaneous COPD-like phenotype and up-regulates Ace2 expression in mice
72 Association Between Blood Eosinophils and Mortality in Critically Ill | COPD
73 The impact of 2011 and 2017 Global Initiative for Chronic Obstructive | COPD
74 Socioeconomic inequality in the use of prescription medications for sm | COPD
75 Maximizing Adherence & Gaining New Information For Your COPD | POR
76 The Salford Lung Study: a pioneering comparative effectiveness approac | POR
77 Incidence and Prognostic Factors of Respiratory Viral Infections in Se | COPD
78 Fluticasone propionate/formoterol for COPD management: a randomized co | COPD
79 Anti-p-benzoquinone antibody level as a prospective biomarker to iden | COPD
80 Prevalence of Asthma Characteristics in COPD Patients in a Dutch Well- | COPD
81 Effect of Changing COPD Triple-Therapy Inhaler Combinations on COPD Symptoms
82 Pneumonia Risk in Severe COPD Linked to Elevated Eosinophil Count
83 Impact of GOLD groups of chronic pulmonary obstructive disease on surg | COPD
84 COPD Research: The Present & Future
85 Withdrawal of Inhaled Corticosteroids in Patients with COPD – A | COPD
86 Predictors of mortality in patients with COPD after 9 years | COPD
87 Role of eosinophils in airway inflammation of chronic obstructive pulm | COPD
88 Healthcare Service Usage and Costs for Elderly Patients with Obstructi | COPD
89 Incidence and outcomes of patients hospitalized with COPD exacerbation | COPD
90 Prevalence of and risk factors for postoperative pulmonary complicatio | COPD
91 Cross-sectional and longitudinal assessment of muscle from regular che | COPD
92 Adherence to treatment recommendations for COPD | COPD
93 Chronic obstructive pulmonary disease with mild airflow limitation: cu | COPD
94 Chronic Obstructive Pulmonary Disease Prescription Patterns | COPD
95 Community pharmacists' knowledge of COPD, and practices and perc | COPD
96 Real-life evaluation of COPD treatment in a Bulgarian population: a 1- | COPD
97 Evaluation of body composition in COPD patients using multifrequency b | COPD
98 Exacerbations and health care resource use among patients with COPD in | COPD
99 The Effects of Low Pressure Domiciliary Non-Invasive Ventilation on Cl | COPD
100 Dual bronchodilator therapy for COPD patients | COPD